Market Cap 89.83M
Revenue (ttm) 56.94M
Net Income (ttm) 4.70M
EPS (ttm) N/A
PE Ratio 20.38
Forward PE N/A
Profit Margin 8.25%
Debt to Equity Ratio 0.00
Volume 14,800
Avg Vol 36,184
Day's Range N/A - N/A
Shares Out 13.78M
Stochastic %K 92%
Beta 0.46
Analysts Strong Sell
Price Target $12.00

Company Profile

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotec...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 808 8400
Address:
One University Plaza, Suite 307, Hackensack, United States
Pacol4
Pacol4 Jul. 26 at 7:59 PM
$CSBR The new CEO's equity compensation seems to be expressing confidence on the data licensing side. 70% is performance based and the lowest target is $15MN in data licensing revenue over any 12 month period. Also from the latest call they appear to be close to funding Corelia ? "And we really hope that over the next couple of months, we're going to be able to fund that company" Can someone confirm whether they have ever said something like this ?
1 · Reply
AdiDasRom
AdiDasRom Jul. 24 at 6:00 PM
$CSBR Let's be serious, because they had a slightly larger loss than estimated given that they are in various stages of research and do not yet have revenues!? Bullish
0 · Reply
AdiDasRom
AdiDasRom Jul. 24 at 2:08 PM
$CSBR very bullish
0 · Reply
HaltTradeAlert
HaltTradeAlert Jul. 24 at 1:34 PM
$CSBR Halt Time: 09:30:48 Issue Symbol: CSBR Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply
JeffreyCress
JeffreyCress Jul. 23 at 8:29 PM
$CSBR great report. Lacking volume/attention.
0 · Reply
JeffreyCress
JeffreyCress Jul. 23 at 8:16 PM
0 · Reply
indievestments
indievestments Jul. 18 at 7:45 PM
$CSBR they finally booted Dr. Ronnie. Seems like scaling the data platform is still a few quarters away.
0 · Reply
DARKP00L
DARKP00L Jul. 18 at 12:31 PM
$CSBR 08:31 on Jul. 18 2025 Champions Oncology Appoints Rob Brainin As CEO, Effective Aug. 25 #tradeideas
0 · Reply
Rasto2020
Rasto2020 Jul. 13 at 8:36 PM
$CSBR inverted head and shoulder on daily .,
0 · Reply
indievestments
indievestments Jul. 13 at 12:35 AM
$CSBR this thing seems like it has a bunch of catalysts but I question managements ability to deliver so soon. But it has been very quiet. Unlocking biotech Corellia value would be sick. And signing a couple PDX TumorBank license agreements. At some point CSBR will run hard and fast. Timing it will be basically impossible. Probably just need hold nose and buy the breakout when it arrives if you have to pay up.
0 · Reply
Latest News on CSBR
Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript

Jul 25, 2025, 7:55 AM EDT - 24 days ago

Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript


Champions Oncology Reports Record Annual Revenue of $57 Million

Jul 23, 2025, 4:00 PM EDT - 26 days ago

Champions Oncology Reports Record Annual Revenue of $57 Million


Champions Oncology Announces Appointment of New CEO

Jul 18, 2025, 8:30 AM EDT - 4 weeks ago

Champions Oncology Announces Appointment of New CEO


Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Mar 11, 2025, 8:07 PM EDT - 5 months ago

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript


Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Dec 11, 2024, 6:02 PM EST - 8 months ago

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript


Champions Oncology Announces Agreement with Weill Cornell Medicine

Oct 16, 2024, 10:55 AM EDT - 10 months ago

Champions Oncology Announces Agreement with Weill Cornell Medicine


Champions Oncology Reports Quarterly Revenue of $14.0 Million

Jul 18, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $14.0 Million


Champions Oncology Reports Quarterly Revenue of $12.0 Million

Mar 12, 2024, 4:30 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $12.0 Million


Champions Oncology Reports Quarterly Revenue of $11.6 Million

Dec 12, 2023, 4:00 PM EST - 1 year ago

Champions Oncology Reports Quarterly Revenue of $11.6 Million


Champions Oncology Reports Quarterly Revenue of $12.6 Million

Sep 13, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.6 Million


Champions Oncology Reports Quarterly Revenue of $13.1 Million

Jul 24, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $13.1 Million


Champions Oncology Announces $5M Stock Repurchase Program

Apr 5, 2023, 9:50 AM EDT - 2 years ago

Champions Oncology Announces $5M Stock Repurchase Program


Champions Oncology Reports Quarterly Revenue of $12.8 Million

Mar 15, 2023, 3:50 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.8 Million


Pacol4
Pacol4 Jul. 26 at 7:59 PM
$CSBR The new CEO's equity compensation seems to be expressing confidence on the data licensing side. 70% is performance based and the lowest target is $15MN in data licensing revenue over any 12 month period. Also from the latest call they appear to be close to funding Corelia ? "And we really hope that over the next couple of months, we're going to be able to fund that company" Can someone confirm whether they have ever said something like this ?
1 · Reply
AdiDasRom
AdiDasRom Jul. 24 at 6:00 PM
$CSBR Let's be serious, because they had a slightly larger loss than estimated given that they are in various stages of research and do not yet have revenues!? Bullish
0 · Reply
AdiDasRom
AdiDasRom Jul. 24 at 2:08 PM
$CSBR very bullish
0 · Reply
HaltTradeAlert
HaltTradeAlert Jul. 24 at 1:34 PM
$CSBR Halt Time: 09:30:48 Issue Symbol: CSBR Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply
JeffreyCress
JeffreyCress Jul. 23 at 8:29 PM
$CSBR great report. Lacking volume/attention.
0 · Reply
JeffreyCress
JeffreyCress Jul. 23 at 8:16 PM
0 · Reply
indievestments
indievestments Jul. 18 at 7:45 PM
$CSBR they finally booted Dr. Ronnie. Seems like scaling the data platform is still a few quarters away.
0 · Reply
DARKP00L
DARKP00L Jul. 18 at 12:31 PM
$CSBR 08:31 on Jul. 18 2025 Champions Oncology Appoints Rob Brainin As CEO, Effective Aug. 25 #tradeideas
0 · Reply
Rasto2020
Rasto2020 Jul. 13 at 8:36 PM
$CSBR inverted head and shoulder on daily .,
0 · Reply
indievestments
indievestments Jul. 13 at 12:35 AM
$CSBR this thing seems like it has a bunch of catalysts but I question managements ability to deliver so soon. But it has been very quiet. Unlocking biotech Corellia value would be sick. And signing a couple PDX TumorBank license agreements. At some point CSBR will run hard and fast. Timing it will be basically impossible. Probably just need hold nose and buy the breakout when it arrives if you have to pay up.
0 · Reply
TI7812
TI7812 Jul. 2 at 3:51 PM
$CSBR just added. Let's see what they report (last year 7/18/24, so mid July). Last quarter "Our third quarter was transformational, marked by our first major data licensing agreement-an important milestone toward monetizing our proprietary data platform." Added Morris, "despite ongoing funding constraints in the pharma and biotech sectors, we continue to drive strong performance in our core services business." "While we anticipate some fluctuations in quarterly revenue, our strategic cost realignment positions us for sustained long-term profitability." Signed one data licensing deal with a total worth of $8M. Recognized $4.5M in the quarter. And wouldn't you know that their profit for the quarter was $4.5M or $0.31/sh fingers crossed they signed another data licensing deal. Or who knows, they don't and maybe stock gets hit, and then can build position at lower cost basis.
0 · Reply
topstockalerts
topstockalerts Jun. 12 at 4:55 PM
$CSBR not a bad place for a swing idea 💡💡💡
0 · Reply
Nate__Foster
Nate__Foster Jun. 12 at 4:41 PM
Yeah NASA dudes FR best group for primo calls. You catch that $AXTI overnight they called at close yesterday? I'm at like plus 50% and holding. Might sell half and just take the ride. $CSBR at open was another amazing call. Those dudes have a crystal ball or something. Great guys.
0 · Reply
Ned__ryerson
Ned__ryerson Jun. 12 at 4:35 PM
$CSBR when are earnings expected? thanks
1 · Reply
topstockalerts
topstockalerts Jun. 12 at 4:29 PM
Top Gainers PT2 $LIMN $CVAC $AXTI $CSBR $KNW
2 · Reply
patb99
patb99 Jun. 12 at 4:18 PM
$CSBR going back on VWAP soon
0 · Reply
Armonica423
Armonica423 May. 11 at 12:35 AM
$CSBR Big exposure for CYDY at 3 oncology conferences this coming week, do your dd research
0 · Reply
CrayP
CrayP May. 7 at 1:56 PM
$CSBR and part of the point is that $CSBR is really selling CRO services to pharma and not mice into academic institutions. Doesn't have the exposure of the others to NIH... that said at least the mice are direct and not indirect costs. What are your indirect costs at Hopkins... gotta be over 60% I would think?
0 · Reply
FDALURKER
FDALURKER May. 6 at 5:31 PM
$CSBR Started buying the June $5 calls here $1.20 for june earnings... Interest should pick up early June with a modest bounce to mid $7's imo... growth is growth even if the sector is hated right now.
0 · Reply
PenkeTrading
PenkeTrading May. 3 at 11:35 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Champions Oncology Inc. Is that bullish or bearish? $CSBR #RsiOversold #NASDAQ
0 · Reply
badtrader21642
badtrader21642 May. 2 at 9:48 PM
$CRL $CSBR What’s the large sellers thesis for selling ? What percentage of biz was mouse based ?
1 · Reply